Gene Therapy for Haemophilia A.

计划入组 14 人 · 首次发布于 2016 年 12 月 23 日

Prevalence of Synovitis in Patients With Haemophilia A

计划入组 300 人 · 首次发布于 2024 年 4 月 8 日

TFPI Levels in Haemophilia A and B Patients

计划入组 100 人 · 首次发布于 2020 年 9 月 30 日

Deimmunised Haemophilia A Therapeutic (Biotest AG)

Haemophilia Type A Therapies (In2Gen)

Turoctocog alfa(Novoeight, Zonovate, NovoEight)

A&A SMALL CHANGES HANDYPEOPLE

United States

Novozymes A/S

Denmark

Ambu A/S

Denmark

UK MHRA Approves Sobi's Efanesoctocog Alfa for Haemophilia A Treatment

European Commission Approves BioMarin's Roctavian for Severe Hemophilia A

Breakthrough in Gene Therapy for Haemophilia A at Christian Medical College, Vellore